Clinical Trial Update: SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in colorectal cancer (locally advanced rectal cancer) is recruiting to evaluate SCRT followed by combination therapy with camrelizumab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING